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Abstract: Feline immunodeficiency virus (FIV), the lentivirus of domestic cats 
responsible for feline AIDS, establishes a latent infection in peripheral blood CD4+ T-cells 
approximately eight months after experimental inoculation. In this study, cats 
experimentally infected with the FIV-C strain in the asymptomatic phase demonstrated an 
estimated viral load of 1 infected cell per approximately 103 CD4+ T-cells, with about  
1 copy of viral DNA per cell. Approximately 1 in 10 proviral copies was capable of 
transcription in the asymptomatic phase. The latent FIV proviral promoter was associated 
with deacetylated, methylated histones, which is consistent with a condensed chromatin 
structure. In contrast, the transcriptionally active FIV promoter was associated with histone 
acetylation and demethylation. In addition, RNA polymerase II appeared to be paused on 
the latent viral promoter, and short promoter-proximal transcripts were detected. Our 
findings for the FIV promoter in infected cats are similar to results obtained in studies of 
human immunodeficiency virus (HIV)-1 latent proviruses in cell culture in vitro studies. 
Thus, the FIV/cat model may offer insights into in vivo mechanisms of HIV latency and 
provides a unique opportunity to test novel therapeutic interventions aimed at eradicating 
latent virus. 
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1. Introduction 
Feline immunodeficiency virus (FIV) is a lentivirus of domestic cats similar to human 
immunodeficiency virus (HIV) in genome structure and immunopathogenesis [1,2], and has been 
utilized as the only naturally occurring animal model of immunodeficiency for HIV infection in  
people [3]. Studies in our laboratory demonstrated that domestic cats experimentally infected with FIV 
enter a state of latency in peripheral blood CD4+ T-cells with concurrent undetectable plasma viremia 
approximately eight months after inoculation. Thus, FIV infection of its natural host can provide 
critical insight into generalizable mechanisms of lentiviral latency and allow for the investigation of 
novel therapeutics targeting latent viral reservoirs. 
2. Viral Load 
To further characterize the latent FIV reservoir during chronic infection, viral DNA loads were 
quantified in peripheral CD4+ T-cells using limiting dilution real-time PCR. CD4+ T-lymphocytes 
were isolated from the peripheral blood of four cats experimentally infected with FIV-Cpgmr [4] in the 
asymptomatic phase (28–32 months post inoculation) using dual magnetic column separation [5]; flow 
cytometry showed that the enriched cell population was greater than 97% CD4+ T-cells. Analyses 
were performed on total CD4+ T cells; within the limitations of the assay, further definition of CD4+ T 
cell sub-populations was not possible. Approximately 106 CD4+ T-cells from each cat were serially 
diluted ten-fold down to 100 cells for subsequent DNA isolation (DNA Micro Kit, Qiagen). DNA copy 
number was measured by real-time PCR for the capsid open reading frame of FIV gag and for a 
portion of the feline interleukin (IL)-2 gene (Figure 1), as previously described [5]. An average of 
0.0013 (standard deviation ±0.0005) FIV copies per cellular equivalents (copies of IL-2 divided by 2) 
were detected and equated to one FIV proviral gag copy per 770 (~103) CD4+ cellular equivalents. 
Thus, the amount of FIV proviral genome copies was ~3 logs less than cellular equivalents with FIV 
gag signal detectable at 104 cells but lost at 103 cells. Based on the limit of detection of ~101 copies 
FIV gag DNA for this assay, we can conclude that on average there was only one provirus per infected 
cell, and one infected cell per 103 CD4+ T-cells. In other words, in 103 cells we would expect on 
average one copy of FIV gag as long as there is only one copy of FIV per infected cell; but given that 
one copy of gag is below our limit of detection, 104 cells would be the necessary to detect FIV DNA 
(which we found to be the case). The FIV proviral DNA load in peripheral CD4+ T-cells was similar 
to that of HIV-infected humans in the asymptomatic phase [6,7]. It has been suggested that the  
FIV-Cpgmr isolate is highly virulent [8]; thus, it is unknown whether the proviral loads found here 
would be similar for other strains of FIV. Though we have previously demonstrated a lack of 2-LTR 
circle junctions in cells latently infected with FIV [5], it should be noted that the PCR assay used here 
does not discriminate between integrated and unintegrated viral species such that these figures may 
provide an over-estimation of proviral load.  
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Figure 1. Quantification of feline immunodeficiency virus (FIV) proviral load in CD4+ T-
cells. Log FIV gag copy number is plotted against the log of calculated cell number (based 
on cellular IL2 gene copies divided by 2) for 4 chronically FIV-infected cats (28–32 
months post infection). Dashed vertical line represents the average cell number at which 
the FIV signal falls below detection level (~103 cells). Error bars represent the standard 
deviation of quadruplicate qPCR measurements. 
 
To determine the amount of replication competent virus in this reservoir, CD4+ T-cells were 
isolated from two of the four FIV-infected cats (34–37 months post inoculation) as above, serially 
diluted from 106 down to 102 cells and cocultured with specific pathogen-free (SPF) feline peripheral 
blood mononuclear cells (PBMC) for 21 days in mitogen (phorbol myristate acetate and concanavalin 
A)-containing medium. Supernatant samples were removed on culture days 7, 14, and 21 for DNA and 
RNA isolation (AllPrep DNA/RNA mini kit, Qiagen), which were assayed for FIV gag RNA and  
2-LTR circle junctions via real-time PCR [5]. On culture days 7 and 21, clarified supernatants were 
transferred to cultures of fresh SPF feline PBMC and assayed for FIV gag DNA after 7 days of 
incubation. CD4+ T-cells from both cats were initially negative for both FIV RNA and 2-LTR circle 
junctions (day 0). After 21 days in culture, cultures of as little as 104 CD4+ T-cells from FIV-infected 
cats were positive for FIV RNA, while cultures containing 105 cells demonstrated infectious 
supernatants and 2-LTR circle junctions (Table 1). Given that there is approximately one provirus in 
every 103 CD4+ T-cells (above), these data indicate that approximately 1 in every 10 proviruses is 
capable of transcription, but, similar to HIV [6,9], only about 1 in 100 proviruses is fully replication 
competent. Limited sensitivity of the supernatant transfer assay, or viral replication restricted to  
cell-to-cell spread, may account for the differences among levels of viral RNA, 2-LTR circle junctions, 
and infectious supernatant observed at the 104 and 105 CD4+ T-cell dilutions. 
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Table 1. Limiting dilution CD4+ T-cells from 2 feline immunodeficiency virus (FIV)-
infected cats cocultured with specific pathogen-free (SPF) feline peripheral blood 
mononuclear cells (PBMC). 
Cat 
Number 
Starting CD4+ 
T-cells 
FIV gag RNA 2-LTR Circle Junction Infectious Supernatant 
d7 d14 d21 d7 d14 d21 d7 d21 
165 
106 + + + + + + + + 
105 + + + + + + - + 
104 + + + + - + - - 
103 - - - - - - - - 
102 - - - - - - - - 
186 
106 + + + + + + + + 
105 + + + + + + - + 
104 - - + - - - - - 
103 - - - - - - - - 
102 - - - - - - - - 
Data are derived from triplicate real-time PCR reactions on cellular DNA (2-LTR CJ, infectious 
supernatant) or cDNA (FIV gag RNA) on day 7 (d7), day 14 (d14), or day 21 (d21). Infectious 
supernatant was detected by the presence of FIV DNA in SPF PBMC cultured for 7 days with 
clarified supernatants. 
3. Chromatin Status 
We hypothesized that histone proteins physically associated with the FIV proviral promoter in 
latently-infected CD4+ T-cells would possess epigenetic modifications associated with a condensed 
chromatin structure [10]. PBMC and CD4+ T-cells were isolated from chronically infected cats as 
described above, and confirmed to be latently infected by detection of FIV gag DNA in the absence of 
detectable FIV gag RNA or 2-LTR circle junction DNA via real-time PCR [5]. Chromatin 
immunoprecipitation (ChIP) was performed on these cells by methods described elsewhere [11], using 
polyclonal rabbit IgG antibodies against either acetylated histone H3 (H3K9,14ac, Millipore), 
methylated histone H3 (H3K27me3, Millipore), or RNA polymerase II (Abcam). All antibodies were 
validated for detection of feline proteins in feline PBMC by Western blot (Figure 2), with polyclonal 
rabbit IgG (Millipore) used as an isotype control. Following ChIP, DNA was assayed by real-time 
PCR for the 5’ FIV LTR, with a forward primer in U3/R and reverse primer in the gag leader 
sequence, and concurrently for the feline housekeeping gene GAPDH. As a comparison to latent 
infection, cultures of PBMC and enriched CD4+ T-cells from infected cats were activated with 
mitogens ex vivo [5], confirmed to be transcriptionally active (detectable FIV gag RNA and 2-LTR 
circle junction DNA), and then examined by ChIP. Positive controls were cultures of PBMC or CD4+ 
T-cells, obtained from healthy uninfected cats, which were inoculated with FIV in vitro; uninfected 
cells served as a negative control for the assay.  
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Figure 2. Validation of three antibodies for use in feline ChIP assays. Feline PBMC 
protein lysate (left) is compared to a positive control of human fetal kidney (293) cell 
protein lysate (right). Appropriate-sized bands are evident in Western blots incubated with 
primary anti-acetylated histone H3 (17 kDa), anti-methylated histone H3 (17 kDa), and 
anti-RNA Polymerase II (220 kDa) antibodies in both lanes. 
 
ChIP analysis showed that the viral promoter in PBMC (Figure 3a) and peripheral CD4+ T-cells 
from FIV-infected cats (Figure 4a) was not associated with acetylated H3. However, an association 
with acetylated H3 was readily detected in the ChIP analysis of the viral promoter in cells activated ex 
vivo with mitogens or infected in vitro (Figure 3b, Figure 4b-c). This relationship remained consistent 
when immunoprecipitated (IP) DNA from transcriptionally active cells was diluted to a level which 
enabled normalization of the input FIV promoter DNA from both active and inactive cell types (data 
not shown). After amplification by real-time PCR, amplicons were electrophoresed on agarose gel to 
visualize the IP band in active cell types (Figure 3c). This band was purified from the gel, sequenced, 
and determined to be identical to the consensus sequence of inoculating virus (data not shown). 
Uninfected cats were negative for FIV LTR sequences in all DNA isolated from ChIP experiments.  
In CD4+ T-cells, the latent FIV promoter was associated with both methylated H3 (Figure 5a) and 
RNA polymerase II (Figure 5b); this association was not detected in transcriptionally active cells. 
These data suggest that the local chromatin environment of the in vivo-derived transcriptionally latent 
FIV promoter is repressive in nature (histone deacetylation and methylation), which may contribute to 
the transcriptional inactivity of the viral promoter. Furthermore, as demonstrated in vitro for  
HIV [12,13], the data indicate that RNA polymerase II remains paused on the FIV LTR. 
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Figure 3. ChIP assay of FIV-infected PBMC using anti-acetylated histone H3 antibody. 
(A) Latently infected (based on undetectable FIV gag RNA) PBMC from three cats were 
below the limit of detection (BLD) for an association of the FIV LTR with acetylated H3, 
and detection of this complex for the fourth cat (184) was not significantly different from 
the background control; (B) Productively infected PBMC represented by a period of viral 
activation in monocytes (184(A)), in vitro infected (IVI) cells, or ex vivo activated (EVA) 
latently infected cells are all significantly associated with acetylated H3. Data are presented 
as the percentage of immunoprecipitated (IP) DNA out of the total input DNA (total 
amount of sheared chromatin DNA used for the assay) with background subtraction using 
a normal IgG control. Error bars represent the standard deviation of triplicate qPCR 
measurements, and data is representative of ChIP experiments repeated a minimum of two 
times between 16 and 29 months post FIV infection; (C) A representative gel image of the 
180 bp FIV LTR products electrophoresed post real-time PCR for in vitro infected 
(transcriptionally active) and in vivo-derived (transcriptionally latent) FIV-infected PBMC. 
The immunoprecipitated (IP) product is detected in transcriptionally active, but not in 
latent, cell types. 
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Figure 4. ChIP assay of FIV-infected CD4+ T-cells using anti-acetylated histone H3 
antibody. (A) Latently infected (based on undetectable FIV gag RNA) CD4+ T-cells from 
all four chronically infected cats are below the limit of detection (BLD) for association of 
the FIV LTR with acetylated H3; (B) Ex vivo activated, productively infected CD4+  
T-cells from 3 FIV-infected cats are all associated with acetylated H3; (C) In vitro infected 
SPF feline CD4+ T-cells are also associated with acetylated H3; (D,E,F) GAPDH positive 
controls are shown for data in A, B, and C respectively. Data are presented as the percentage 
of immunoprecipitated (IP) DNA out of the total input DNA with background subtraction 
using a normal IgG control. Error bars represent the standard deviation of triplicate qPCR 
measurements, and experiments were performed between 24 and 32 months post FIV 
infection. 
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Figure 5. ChIP assay of FIV-infected CD4+ T-cells using anti-methylated histone H3 and 
anti-RNA Polymerase II antibodies. (A) The FIV promoter of latently-infected, but not ex 
vivo activated (EVA) [5], CD4+ T-cells is associated with methylated H3; (B) The FIV 
promoter of latently-infected, but not ex vivo activated (EVA), CD4+ T-cells is associated 
with RNA Polymerase II; (C,D) GAPDH positive controls are shown for A and B 
respectively. Data are presented as the percentage of immunoprecipitated (IP) DNA out of 
the total input DNA with background subtraction using a normal IgG control. Error bars 
represent the standard deviation of triplicate qPCR measurements, and data is representative 
of ChIP experiments repeated in two different cats (A/C: cat #184 and #187, B/D: cat #165 
and #187) between 29 and 32 months post FIV infection. 
 
4. Short Transcripts 
To characterize the FIV transcriptional profile during latency, RNA was isolated using TRIzol 
(Invitrogen) from freshly isolated, latently infected (as defined by lack of viral gag mRNA) CD4+  
T-cells and assayed for promoter-proximal short FIV transcripts by real-time PCR. Such short 
transcripts are consistent with pausing of the RNA polymerase complex [14]. Primer sets for FIV gag 
capsid, a 66-nucleotide region of R (+1 to +66), a 118-nucleotide region of R-U5 (+1 to +118), and an 
87-nucleotide region at the 3’ terminus of the orfA gene were used. Only the short R fragment could be 
detected in freshly-isolated, latent CD4+ T-cells (Table 2). Copy number was normalized to GAPDH 
cDNA, and all viral transcripts (gag, R, R-U5, orfA) were detected in cells with active FIV replication. 
These data suggest that RNA polymerase II paused on the FIV promoter has limited processivity, as 
observed in PBMC from individuals infected with HIV [15], thereby transcribing a short R segment, 
but not extending into the viral gag gene (necessary for viral replication). This is particularly intriguing 
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given that FIV is not known to encode a potent transcriptional transactivator (like HIV Tat) [16,17], 
and may imply that the promoter-associated repressive chromatin structure itself is highly relevant  
to latency. 
Table 2. Real-time PCR amplifications of cDNA isolated from FIV-infected CD4+ T-
cells. 
Cat Number Gag Copies R Copies R-U5 Copies OrfA Copies 
165 BLD 16,000 (±2,000) BLD BLD 
184 BLD 30,000 (±20,000) BLD BLD 
186 BLD 3,900 (±900) BLD BLD 
187 BLD 20,000 (±10,000) BLD BLD 
184(A) 1,600 (±100) 690,000 (±60,000) 1,200 (±100) 3,100 (±300) 
Data are presented as the mean (± standard deviation) of triplicate PCR measurements per 106 copies 
feline GAPDH cDNA, and are representative of CD4+ T-cell isolation at two different time points 
(30–34 months post FIV infection) for each cat. Sample labeled 184(A) represents PBMC from cat 
184 during a period of viral activation in blood monocytes; BLD indicates values below the limit of 
detection. 
5. Conclusions 
In summary, this study demonstrated similarity in T-cell proviral loads and infectious virus between 
FIV-infected cats and HIV-infected individuals, as well as parallels between the in vivo transcriptional 
status of each of these viruses in their respective hosts’ CD4+ T-cells. Importantly, we implicated 
chromatin remodeling in the regulation of the latent FIV promoter in vivo; similarly, in vitro studies 
support the role of post-translational modifications of histones in the control of HIV-1 transcription [10]. 
During highly active antiretroviral therapy (HAART), HIV persists in infected individuals as a 
transcriptionally inactive (latent) integrated provirus [18], and memory CD4+ T-cells are the primary 
long-lived lentiviral reservoir [19–21]. Multiple molecular mechanisms may underlie the establishment 
and maintenance of latently infected cellular reservoirs [10,22], including epigenetic modification of 
histone proteins in chromatin [23–25]. Accordingly, FIV-infected cats provide an in vivo model of 
lentiviral latency in its natural host and may help to address questions that are either logistically or 
ethically not feasible to explore in HIV-infected humans, including the investigation of novel  
anti-latency therapeutic approaches [26]. 
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